Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

Recombinant Human Glucagon/GCG Protein (His Tag)– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

This product has been added to the cart.

Recombinant Human Glucagon/GCG Protein (His Tag)

SKU: PKSH032491-50

  • $ 53395



Recombinant Human Glucagon/GCG Protein (His Tag)

 

SKU # PKSH032491
Expression Host HEK293 Cells

 

 

Description

Synonyms GCG, GLP-1, GLP-2, GRPP, Glicentin, Glicentin-Related Polypeptide, Glucagon, Glucagon-Like Peptide 1, Glucagon-Like Peptide 2, Glucagon-like Peptide 1, Incretin Hormone, OXM, OXY, Oxyntomodulin
Species Human
Expression Host HEK293 Cells
Sequence Arg21-Lys180
Accession P01275
Calculated Molecular Weight 18.6 kDa
Observed Molecular Weight 19 kDa
Tag C-His
Bio-activity Not validated for activity
  

 

Properties

Purity > 95 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Formulation Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 200mM NaCl, 1mM DTT, 50% Glycerol, pH 8.0.
Reconstitution Not Applicable



Background

Glucagon is a secreted protein and belongs to the glucagon family. Glucagon can be cleved into 8 chains, playing an important role in initiating and maintaining hyperglycemic conditions in diabetes. Glucagon can regulates blood glucose by decreasing glycolysis and increasing gluconeogenesis. In addition, Glucagon is involved in initiating and maintaining hyperglycemic conditions in diabetes. Glucagon release is stimulated by hypoglycemia and inhibited by hyperglycemia, insulin, and somatostatin. In the glucagon antagonist, His-53 and Phe-58 are missing. This antagonist has been successfully utilized to reduce glucose concentration in vivo.